2016-08-12T08:05:18-05:00 2015-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVENUE SUITE 500 BETHESDA MD 20814 990 2015-01-01 522252820 GENERIC PHARMACEUTICAL ASSOCIATION GENE 2022497100 777 6TH STREET NW NO 510 WASHINGTON DC 20001 CHESTER G DAVIS JR PRESIDENT & CEO 2022497100 2016-08-11 1 HOLLY CAPORALE P00235685 3019860600 2016-08-11 2015 2016-12-15 16:53:06Z CHESTER G DAVIS JR 777 6TH STREET NW NO 510 WASHINGTON DC 20001 16453215 0 X WWW.GPHAONLINE.ORG X 2000 DC PROMOTES THE INTERESTS OF ENTITIES ENGAGED IN THE GENERIC PHARMACEUTICAL INDUSTRY. 14 14 30 209 0 0 0 0 12371598 16448699 6985 2425 0 2091 12378583 16453215 86750 118500 0 0 5804815 6027309 0 0 0 6205751 6853857 12097316 12999666 281267 3453549 9287669 13288275 2920438 3467495 6367231 9820780 THE ORGANIZATION FOSTERS AND PROMOTES THE INTERESTS OF ENTITIES ENGAGED IN THE GENERIC PHARMACEUTICAL INDUSTRY. 0 0 GOVERNMENT AFFAIRS - ADVOCATE ON BEHALF OF THE GENERIC PHARMACEUTICAL INDUSTRY WITH RESPECT TO FEDERAL, STATE AND MUNICIPAL RULES, LAWS AND ORDERS AFFECTING THE INDUSTRY. MEMBERSHIP SERVICES - PROVIDE MEMBERS WITH NEWS AND PUBLICATIONS REGARDING THE GENERIC PHARMACEUTICAL INDUSTRY THROUGH E-DIGEST, GPHA INSIDER (A QUARTERLY NEWSLETTER), ANNUAL REPORTS AND MEETINGS AND CONFERENCES. SCIENCE & REGULATORY LANGUAGE - FACILITATE AND ORGANIZE MEMBER COMPANY INITIATIVES RELATED TO SCIENCE AND REGULATORY MATTERS AFFECTING THE GENERIC PHARMACEUTICAL INDUSTRY; WORK WITH THE AGENCIES OF THE U.S. GOVERNMENT (E.G. FDA, DEA, FTC) AND SIMILAR INTERNATIONAL AGENCIES WITH RESPECT TO THEIR GUIDANCES, GUIDELINES, RULES AND REGULATIONS AFFECTING THE GENERIC PHARMACEUTICAL INDUSTRY. 0 0 0 1 0 0 0 0 0 1 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 1 44 0 1 30 1 0 0 0 0 0 0 X 14 14 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X THE ASSOCIATION 2022497100 777 6TH STREET NW NO 510 WASHINGTON DC 20001 CRAIG WHEELER CHAIR 1.00 X X 0 0 0 DOUG BOOTHE SECRETARY/TREASURER 1.00 X 0 0 0 JEFF WATSON DIRECTOR 1.00 X 0 0 0 PETER GOLDSCHMIDT DIRECTOR 1.00 X X 0 0 0 MARCY MACDONALD DIRECTOR 1.00 X 0 0 0 DEBRA BARRETT DIRECTOR 1.00 X 0 0 0 JOSEPH RENNER DIRECTOR 1.00 X 0 0 0 JOHN DUCKER DIRECTOR 1.00 X 0 0 0 CHIRAG PATEL DIRECTOR 1.00 X 0 0 0 PAUL MCGARTY DIRECTOR 1.00 X 0 0 0 JIM KEDROWSKI DIRECTOR 1.00 X 0 0 0 BERTRAND C LIANG DIRECTOR 1.00 X 0 0 0 TONY PERA DIRECTOR 1.00 X 0 0 0 HEATHER BRESCH VICE CHAIR 1.00 X X 0 0 0 RALPH NEAS PRESIDENT & CEO, PAST 40.00 X 809576 0 25557 CHESTER DAVIS PRESIDENT & CEO 40.00 X 410857 0 16080 CHRISTINE SIMMON SR. VP POLICY & STRATEGY 40.00 X 586590 0 41818 JONATHAN MARKS VP OF INTL AFFAIRS 40.00 X 331431 0 17050 FELICIA TAN ASSC VP OF SCI AND REG AFFAIRS 40.00 X 264384 0 28707 DAVID GAUGH SR. VP OF SCI & REG AFFAIRS 40.00 X 653551 0 47214 MELISSA MANN SR VP GOVERNMENT AFFAIRS 40.00 X 322695 0 18856 GORDON JOHNSTON FORMER VP REG. SCIENCE 0.00 X 241830 0 0 ROBERT BILLINGS SENIOR ADVISOR TO THE PRES 0.00 X 190537 0 0 3811451 0 195282 20 1 1 0 CORE STAGING 1137 EAST MARION ST BOX 228 SHELBY NC 28150 MEETING & PRODUCTION SERVICES 436478 SPENCER STUART PO BOX 98991 CHICAGO IL 60693 EXECUTIVE SEARCH 290814 MFJ INTERNATIONAL 1032 29TH ST NW WASHINGTON DC 20036 INTL LOBBYING & CONSULTING SERVICES 260000 KOUNTOUPES DENHAM 1333 H ST NW SUITE 1100 WEST WASHINGTON DC 20005 LOBBYING AND CONSULTING SERVICES 255000 OBER KALER 100 LIGHT STREET 19TH FLOOR BALTIMORE MD 21298 LEGAL SERVICES 246575 15 MEMBERSHIP DUES 900099 11154982 11154982 MEETING REVENUE 900099 3994034 3994034 BIOSIMILAR DIVISIONAL DUES 900099 1299683 1299683 16448699 2425 2425 MISCELLANEOUS 900099 2091 2091 0 2091 16453215 16450790 0 2425 118500 1112670 4292936 170288 209865 241550 287407 29322 2565815 1068698 84945 53135 371206 199587 1626821 119603 35825 RESEARCH & STUDY PROJEC 248406 DUES & SUBSCRIPTIONS 123909 39178 12999666 5512415 9404235 36475 155595 154133 271586 901621 306863 699507 594758 2773157 2775581 111982 86520 9287669 13288275 1038584 850461 1197835 1888569 684019 728465 2920438 3467495 X 6367231 9820780 6367231 9820780 9287669 13288275 3453549 0 X X 0 1 X 1 0 0 0 1 11154982 3311365 194338 3505703 3346495 159208 452469 80556 371913 328952 132818 196134 120200 93489 26711 594758 CERTIFICATE OF DEPOSITS 2775581 C 2775581 DEFERRED RENT 641945 DEFERRED COMPENSATION PAYABLE 86520 728465 X PART X, LINE 2: THE ASSOCIATION REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ASSOCIATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. 0 THE CHILDRENS HOSPITAL OF PHILADELPHIA FOUNDATION 34TH ST CIVIC CENTER BLVD PHILADELPHIA PA 19104 232237932 501(C)(3) 5000 GENERAL SUPPORT CHRIST HOUSE 1717 COLUMBIA ROAD NW WASHINGTON DC 20009 521362103 501(C)(3) 5000 GENERAL SUPPORT CITIZENS AGAINST GOVERNMENT WASTE 1301 PENNSYLVANIA AVENUE NW SUITE 1075 WASHINGTON DC 20004 521363952 501(C)(3) 10000 GENERAL SUPPORT GBS CIDP FOUNDATION INTERNATIONAL 104 1/2 FORREST AVENUE NARBERTH PA 19072 222474769 501(C)(3) 25000 GENERAL SUPPORT JDRF 26 BROADWAY 14TH FLOOR NEW YORK NY 10004 231907729 501(C)(3) 5000 GENERAL SUPPORT MEMORIAL SLOAN KETTERING CANCER CENTER 633 THIRD AVENUE 28TH FLOOR NEW YORK NY 10017 131924236 501(C)(3) 5000 GENERAL SUPPORT NATIONAL COALITION ON HEALTH CARE 1825 K STREET NW SUITE 411 WASHINGTON DC 20006 521687849 501(C)(3) 25000 GENERAL SUPPORT UNITY HEALTH CARE 1220 12TH STREET SE SUITE 120 WASHINGTON DC 20003 521572431 501(C)(3) 10000 GENERAL SUPPORT PAN MASSACHUSETTS CHALLENGE 77 4TH AVENUE NEEDHAM MA 02494 042746912 501(C)(3) 5000 GENERAL SUPPORT WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 521071570 501(C)(3) 10000 GENERAL SUPPORT 10 0 X 1 1 X X X X 1 1 0 RALPH NEAS PRESIDENT & CEO, PAST 414562 0 180000 0 215014 0 20800 0 4757 0 835133 0 0 0 CHESTER DAVIS PRESIDENT & CEO 260857 0 150000 0 0 0 0 0 16080 0 426937 0 0 0 CHRISTINE SIMMON SR. VP POLICY & STRATEGY 350690 0 235900 0 0 0 18000 0 23818 0 628408 0 0 0 JONATHAN MARKS VP OF INTL AFFAIRS 219631 0 103200 0 8600 0 12797 0 4253 0 348481 0 0 0 FELICIA TAN ASSC VP OF SCI AND REG AFFAIRS 205104 0 59280 0 0 0 13254 0 15453 0 293091 0 0 0 DAVID GAUGH SR. VP OF SCI & REG AFFAIRS 388551 0 265000 0 0 0 20800 0 26414 0 700765 0 0 0 MELISSA MANN SR VP GOVERNMENT AFFAIRS 272695 0 50000 0 0 0 0 0 18856 0 341551 0 0 0 GORDON JOHNSTON FORMER VP REG. SCIENCE 241830 0 0 0 0 0 0 0 0 0 241830 0 0 0 ROBERT BILLINGS SENIOR ADVISOR TO THE PRES 190537 0 0 0 0 0 0 0 0 0 190537 0 190537 0 PART I, LINES 4A-B PART I, LINE 4A: ROBERT BILLINGS RECEIVED A SEVERANCE PAYMENT OF $190,537. PART I, LINE 4B: RALPH NEAS PARTICIPATED IN A NONQUALIFIED RETIRMENT PLAN. THE PLAN ACCEPTS ONLY EMPLOYEE CONTRIBUTIONS. THERE ARE NO EMPLOYER CONTRIBUTIONS. PART II, (8) GORDON JOHNSTON IS A FORMER EMPLOYEE RECEIVING PAYMENTS AS A CONSULTANT DBA GORDON JOHNSTON REGULATORY CONSULTANTS GORDON JOHNSTON DBA GORDON JOHNST FORMER VP REG. SCIENCE 241830 INDEPENDENT CONTRACTOR & CONSULTANT 0 FORM 990, PART VI, SECTION A, LINE 6 GPHA HAS ONE CLASS OF REGULAR VOTING MEMBERS THAT MUST MEET THE FOLLOWING CRITERIA. A REGULAR MEMBER SHALL BE A CORPORATION, PARTNERSHIP OR OTHER LEGAL ENTITY THAT DERIVES MORE THAN FIFTY PERCENT (50%) OF ITS NET REVENUES IN THE UNITED STATES FROM THE DEVELOPMENT, COMMERCIALIZATION, MANUFACTURE, SALE AND/OR MARKETINGS OF FINISHED DOSE PRODUCTS THAT ARE (1) PRODUCTS DESCRIBED IN ABBREVIATED NEW DRUG APPLICATIONS FILED WITH THE U.S. FOOD & DRUG ADMINISTRATION; (2) PRODUCTS SOLD AS AUTHORIZED GENERIC DRUGS IN THE U.S., (3) BIOSIMILAR AND BIOGENERIC PRODUCTS, AS DESCRIBED IN SECTION 351(K) OF THE PUBLIC HEALTH SERVICE ACT, AS AMENDED; AND/OR (4) DRUG EFFICACY STUDY IMPLEMENTATION (DESI) PRODUCTS. REGULAR MEMBERS HAVE FULL VOTING RIGHTS ON A "ONE COMPANY, ONE VOTE" BASIS. EACH REGULAR MEMBER SHALL DESIGNATE IN WRITING ONE PERSON TO EXERCISE THE RIGHTS OF THE REGULAR MEMBER IN THIS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A GPHA'S VOTING MEMBERS ELECT THE DIRECTORS OF GPHA'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B PURSUANT TO GPHA'S BYLAWS, THE VOTING MEMBERS HAVE THE AUTHORITY TO AMEND THE BYLAWS. FURTHER, PURSUANT TO THE D.C. NOT-FOR-PROFIT CORPORATION ACT, EXTRAORDINARY ACTIONS MUST BE APPROVED BY THE VOTING MEMBERS. FORM 990, PART VI, SECTION B, LINE 11 GPHA STAFF AND LEGAL COUNSEL PROVIDE INITIAL REVIEW OF THE FORM 990. THE FORM 990 IS THEN REVIEWED BY THE AUDIT & FINANCE COMMITTEE. FINALLY IT IS FORWARDED TO ALL THE DIRECTORS OF THE BOARD BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C GPHA REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY BY REMINDING DIRECTORS AND OTHERS SUBJECT TO THE POLICY PERIODICALLY OF THE APPLICABILITY OF THE POLICY AND THE APPROPRIATE MANNER OF COMPLYING WITH THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF THE PRESIDENT IS DETERMINED BASED ON THE PERFORMANCE OF THE PRESIDENT AND COMPARABLE SALARIES OF EXECUTIVES OF SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FINAL APPROVAL OF THE PRESIDENT'S COMPENSATION IS MADE BY THE EXECUTIVE COMMITTEE OF THE BOARD, ALL OF WHOM ARE INDEPENDENT DIRECTORS. COMPENSATION OF OTHER OFFICERS AND KEY EMPLOYEES IS DETERMINED BY THE PRESIDENT BASED ON COMPENSATION DATA OF SIMILARLY SITUATED EMPLOYEES AT SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 99, PART XII, LINE 2C THE AUDIT & FINANCE COMMITTE OF THE BOARD OVERSEES THE AUDIT AND RECOMMENDS SELECTION OF AN INDEPENDENT AUDITOR BY THE BOARD. THIS PROCESS HAS NOT CHANGED FROM PRIOR YEAR. AFFORDABLE MEDICINE RESEARCH INSTITUTEINC (AMRI) 777 6TH STREET NW STE 510 WASHINGTON DC 20001 453526383 SEE PART VII - SUPPLEMENTAL INFORMATION DC 501(C)(3) LINE 7 GENERIC PHARMACEUTICAL ASSOCIATION 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 PART II, COLUMN B PRIMARY ACTIVITY: AFFORDABLE MEDICINE RESEARCH INSTITUTE IS A 501(C)(3) TAX-EXEMPT, EDUCATIONAL ORGANIZATION WITH THE MISSION OF INCREASING UNDERSTANDING OF, ACCESS TO AND UTILIZATION OF SAFE, EFFECTIVE AND AFFORADBLE PHARMACEUTICALS.